Mr Nigel DavisCEO
MediSieve is a London-based medical device therapeutics company developing “magnetic blood filtration”, a revolutionary method of treating blood-borne diseases by removing pathogens, toxins or other targets directly from a patient’s bloodstream. Practically any component can be specifically removed (cytokines, toxins, cells etc.), providing a platform technology that could be used to treat a huge range of blood-borne medical conditions, accessing several billion-dollar global markets. Our initial targets are sepsis, cytokine storms, leukaemia and malaria.